Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults

American Journal of Clinical Nutrition

Volumn 86, Issue 5, 2007, Pages 1405-1413

  Hoey, Leane ^a   McNulty, Helene ^a   Askin, Nadina ^a   Dunne, Adrian ^b   Ward, Mary ^a   Pentieva, Kristina ^a   Strain, J J ^a   Molloy, Anne M ^c   Flynn, Cliona A ^a   Scott, John M ^c  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adults; B vitamins; Biomarkers; Dietary folate equivalents; Folate; Folic acid; Food fortification; Intakes; Plasma homocysteine

Indexed keywords

BIOLOGICAL MARKER; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; RIBOFLAVIN; VITAMIN B GROUP;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; FEEDING BEHAVIOR; FEMALE; HUMAN; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 36248993031     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.5.1405     Document Type: Article

References (59)

1. Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid: final rule. Fed Regist 1996;61:8781-97.
2. Green-Raleigh K, Carter H, Mulinare J, Prue C, Petrini J. Trends in folic acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995-2005. Matern Child Health J 2006;10(suppl):S177-82.
3. Choumenkovitch SF, Selhub J, Wilson PWF, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002;132:2792-8.
4. Jacques PF, Selhub J, Bostom AG, Wilson PWF, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
5. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005;82:442-50.
6. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LYC. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
7. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DEC. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047-8.
8. Castilla EE, Orioli IM, Lopez-Camelo JS, da Graca Dutra M, Nazer-Herrera J. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet 2003;123A:123-8.
9. Food Safety Authority of Ireland. Report of the National Committee on folic acid food fortification. Dublin, Ireland: Food Safety Authority of Ireland, 2006.
10. Food Standards Australia New Zealand. Consideration of mandatory fortification with folic acid. 4 October 2006. Internet: http://www. foodstandards.gov.au/standardsdevelopment/proposals/proposalp295consider2600. cfm (accessed 11 January 2007).
11. Scientific Advisory Committee on Nutrition. Folate and disease prevention. London, United Kingdom: Her Majesty's Stationery Office, 2006. Internet: http://www.sacn.gov.uk/reports/# (accessed 11 January 2007).
12. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomized trials. BMJ 1998;316:894-8.
13. Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency. A dose-finding trial. Arch Intern Med 2005;165:1167-72.
14. McKinley MC, McNulty H, McPartlin J, et al. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 2001;73:759-64.
15. McNulty H, Dowey L, Strain JJ, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C→T polymorphism. Circulation 2006;113:74-80.
16. Yang Q, Botto LD, Erickson JD, et al. Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 2006;113:1335-43.
17. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007;369:1876-82.
18. Dickinson CJ. Does folic acid harm people with vitamin B12 deficiency? Q J Med 1995;88:357-64.
19. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1999;10:66-88.
20. Cole BF, Baron JH, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-9.
21. European Commission Health and Consumer Protection Directorate-General. Discussion paper on the setting of maximum and minimum amounts for vitamins and minerals in foodstuffs. Brussels, Belgium: European Communities, 2006.
22. Botto LD, Lisi A, Robert-Gnansia E, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005;330:571-6.
23. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
24. Food Standards Agency. Food portion sizes. 3rd ed. London, United Kingdom: Her Majesty's Stationery Office, 2002.
25. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39C:5-41.
26. Black AE. Critical evaluation of energy intake using the Goldberg cutoff for energy intake: basal metabolic rate. A practical guide to its calculation, use and limitations. Int J Obes Relat Metab Disord 2000;24:1119-30.
27. Leino A. Fully automated measurement of total homocysteine in plasma and serum on the Abbott IMx Analyzer. Clin Chem 1999;45:569-71.
28. Molloy AM, Scott JM. Microbiological assay for serum, plasma and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997;281:43-53.
29. Kelleher BP, O'Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtiter plates. J Clin Pathol 1991;44:592-5.
30. Bates CJ, Pentieva KD, Matthews N, Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Clin Chim Acta 1999;280:101-11.
31. Powers HJ, Bates CJ, Prentice AM, Lamb WH, Jepson M, Bowman H. The relative effectiveness of iron and iron with riboflavin in correcting a microcytic anaemia in men and children in rural Gambia. Hum Nutr Clin Nutr 1983;37C:413-25.
32. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
33. Department of Health. Report on health and social subjects 41: dietary reference values for food energy and nutrients for the United Kingdom. London, United Kingdom: Her Majesty's Stationery Office, 1991.
34. Institute of Medicine. Subcommittee on folate, other B-vitamins and choline. Dietary reference intakes: thiamine, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC: National Academy Press, 1998.
35. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995;274:1696-702.
36. Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666-9.
37. Choumenkovitch SF, Jacques PF, Nadeau MR, Wilson PWF, Rosenberg IH, Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001;131:3277-80.
38. Hirsch S, de la Maza P, Barrera G, Gattas V, Petermann M, Bunout D. The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B12 deficiency in elderly people. J Nutr 2002;132:289-91.
39. Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006;367:1352-61.
40. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-9.
41. McNulty H, Pentieva K. Folate bioavailability. Proc Nutr Soc 2004;63:529-36.
42. Busby A, Armstrong B, Dolk H, et al. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 2005;20:393-402.
43. The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. JAMA 2004;291:565-75.
44. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006;354:1567-77.
45. The Norwegian Vitamin Trial (NORVIT). Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1629-32.
46. B-Vitamin Treatment Trialists' Collaboration. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 2006;151:282-7.
47. Mills JL, Von Kohorn I, Conley MR, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr 2003;77:1474-7.
48. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007;85:193-200.
49. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr 1999;19:357-77.
50. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993;86:703-8.
51. Suarez L, Hendricks K, Felkner M, Gunter E. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 2003;13:81-8.
52. Liaugaudas G, Jacques PF, Selhub J, Rosenberg IH, Boston AG. Renal insufficiency, vitamin B-12 status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol 2001;21:849-51.
53. Robertson J, Lemolo F, Stabler SP, Allen RH, Spence JD. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. Can Med Assoc J 2005;172:1569-73.
54. Quinlivan EP, McPartlin J, McNulty H, et al. Importance of both folic acid and vitamin B-12 in reduction of risk of vascular disease. Lancet 2002;359:227-8.
55. Pan American Health Organization, Centers for Disease Control and Prevention, March of Dimes Birth Defects Foundation, United Nations Children's Fund and Institute of Nutrition and Food Technology, University of Chile. Flour fortification with iron, folic acid and vitamin B12. Washington, DC: Pan American Health Organization, 2004.
56. Gray P. Perspectives on European (EU) legislation on fortified food. Scand J Nutr 1999;43(suppl):97S-100S.
57. Galvin MA, Kiely M, Flynn A. Impact of ready-to-eat breakfast cereal (RTEBC) consumption on adequacy of micronutrient intakes and compliance with dietary recommendations in Irish adults. Public Health Nutr 2003;6:351-63.
58. van den Boom A, Serra-Majem L, Ribas L, et al. The contribution of ready-to-eat cereals to daily nutrient intake and breakfast quality in a Mediterranean setting. J Am Coll Nutr 2006;25:135-43.
59. Preziosi P, Galan P, Deheeger M, Yacoub N, Drewnowski A, Hercberg S. Breakfast type, daily nutrient intakes and vitamin and mineral status of French children, adolescents and adults. J Am Coll Nutr 1999;18:171-8.